Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress

Go back to Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
(NASDAQ: KRYS) Delayed: 340.21 -3.22 (0.94%)
Previous Close $343.43    52 Week High
Open $339.21    52 Week Low
Day High $346.82    P/E N/A 
Day Low $337.60    EPS
Volume 272,720